Paul Savage

11PUBLICATIONS
79CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Deep learningMolecular targetsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 16, 2026
A chromatin-informed transcriptional regulatory framework to stratify patients and guide therapy selection in triple-negative breast cancer.

|Jul 22, 2026
Durable Cancer Control and Extended Long-Term Survival Following Salvage Surgery for Squamous Cell Carcinoma of the Anal Canal: A Cohort Study.

|May 26, 2026
A Consensus Approach to the Incorporation of Total Neoadjuvant Therapy in a Treatment Algorithm for Stage I-III Resectable Rectal Cancer.

|May 06, 2024
Use of Deep Learning to Evaluate Tumor Microenvironmental Features for Prediction of Colon Cancer Recurrence.

Frank A Sinicrope, Garth D Nelson, Bahar Saberzadeh-Ardestani

|Feb 29, 2024
Improved Risk-Stratification Scheme for Mismatch-Repair Proficient Stage II Colorectal Cancers Using the Digital Pathology Biomarker QuantCRC.

Christina Wu, Reetesh K Pai, Heidi Kosiorek

|Jun 04, 2021
STAT1 potentiates oxidative stress revealing a targetable vulnerability that increases phenformin efficacy in breast cancer.

Stephanie P Totten, Young Kyuen Im, Eduardo Cepeda Cañedo

Pageof 2

Frequent Collaborators

4 joint publications

Morag Park

2 joint publications

Rondell P Graham

2 joint publications

Vincent Giguère

2 joint publications

Christina Wu